Article
Rational approaches to resistance: using saquinavir.
AIDS (London, England) - 1 Nov 1996
Boucher C
Abstract excerpt
AIM: To review drug-resistance patterns of HIV protease inhibitors, with particular reference to saquinavir, and how resistance and cross-resistance patterns may influence disease management. RESISTANCE TO SAQUINAVIR: Resistance to saquinavir in vitro and in vivo is associated with mutations L90M and G48V in HIV protease. L90M is the predominant mutation in vivo. Clinically, G48V is uncommon and the double...
Topics
- Anti-HIV Agents
- Drug Resistance, Microbial
- Drug Therapy, Combination
- Genotype
- HIV
- HIV Infections
- HIV Protease
- HIV Protease Inhibitors
- Humans
- Point Mutation
- Saquinavir
